nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adeno-associated virus-vectored delivery of HIV biologics: the promise of a “single-shot” functional cure for HIV infection
|
Hahn, Patricia A. |
|
|
9 |
1 |
p. |
artikel |
2 |
Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa
|
Mofokeng, Nombuyiselo |
|
|
9 |
1 |
p. |
artikel |
3 |
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
|
Schwarz, M. |
|
|
9 |
1 |
p. |
artikel |
4 |
Editorial Board
|
|
|
|
9 |
1 |
p. |
artikel |
5 |
Editorial JVE 9.1
|
|
|
|
9 |
1 |
p. |
artikel |
6 |
Heat shock protein: a double-edged sword linking innate immunity and hepatitis B virus infection
|
Dai, Wen-ying |
|
|
9 |
1 |
p. |
artikel |
7 |
Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA
|
Archin, N. |
|
|
9 |
1 |
p. |
artikel |
8 |
Highlights from the 30th Conference on Retroviruses and Opportunist Infections (CROI)
|
Psomas, K.C. |
|
|
9 |
1 |
p. |
artikel |
9 |
Influencing factors and adverse outcomes of virologic rebound states in anti-retroviral-treated individuals with HIV infection
|
Yuan, Defu |
|
|
9 |
1 |
p. |
artikel |
10 |
Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents
|
Cheng, Pin-Nan |
|
|
9 |
1 |
p. |
artikel |
11 |
The poliovirus re-emergence: did concentrated efforts against COVID-19 open the door?
|
Shaheen, Nour |
|
|
9 |
1 |
p. |
artikel |